Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.58%1.2B | 1.50%1.21B | 9.98%1.26B | 6.70%4.65B | 2.65%1.18B | 6.43%1.14B | 8.78%1.2B | 9.24%1.14B | 9.37%4.36B | 7.59%1.15B |
| Cost of revenue | 1.96%631.79M | -2.58%634.71M | 5.84%655.99M | 5.74%2.52B | 1.04%627.8M | 5.56%619.67M | 10.31%651.51M | 6.29%619.78M | 1.86%2.38B | 3.64%621.36M |
| Gross profit | 9.95%566.67M | 6.38%579.49M | 14.89%601.19M | 7.86%2.13B | 4.55%549.26M | 7.49%515.41M | 7.01%544.71M | 12.95%523.27M | 20.03%1.98B | 12.68%525.35M |
| Operating expense | 9.57%364.03M | 9.46%349.84M | 12.90%349.74M | 12.00%1.29B | 13.36%335.52M | 12.38%332.25M | 9.42%319.61M | 13.29%309.79M | 22.30%1.15B | 14.68%295.98M |
| Staff costs | ---- | ---- | ---- | 10.35%590.62M | ---- | ---- | ---- | ---- | 28.98%535.22M | ---- |
| Selling and administrative expenses | 0.36%56.92M | 9.68%53.38M | 17.60%58.5M | 19.39%210.79M | 25.04%55.66M | 25.58%56.72M | 9.29%48.67M | 17.48%49.74M | 16.80%176.55M | 11.40%44.52M |
| -General and administrative expense | 0.36%56.92M | 9.68%53.38M | 17.60%58.5M | 19.39%210.79M | 25.04%55.66M | 25.58%56.72M | 9.29%48.67M | 17.48%49.74M | 16.80%176.55M | 11.40%44.52M |
| Depreciation and amortization | ---- | ---- | ---- | 10.32%334.97M | ---- | ---- | ---- | ---- | 14.59%303.63M | ---- |
| -Depreciation | ---- | ---- | ---- | 10.31%332.17M | ---- | ---- | ---- | ---- | 14.58%301.13M | ---- |
| -Amortization | ---- | ---- | ---- | 12.32%2.81M | ---- | ---- | ---- | ---- | 15.63%2.5M | ---- |
| Other operating expenses | 11.02%315.01M | 9.92%309.88M | 11.62%304.03M | 17.71%198.42M | 11.99%290.96M | 10.25%283.74M | 10.88%281.92M | 13.76%272.37M | 24.19%168.56M | 157.32%259.8M |
| Total other operating income | -3.88%7.89M | 22.20%13.42M | 3.72%12.78M | 40.93%42.62M | 33.23%11.1M | 19.27%8.21M | 63.62%10.98M | 48.27%12.33M | 28.66%30.24M | -2.72%8.33M |
| Operating profit | 10.64%202.64M | 2.02%229.65M | 17.79%251.45M | 2.07%840.47M | -6.81%213.74M | -0.38%183.16M | 3.76%225.11M | 12.46%213.48M | 16.98%823.44M | 10.20%229.37M |
| Net non-operating interest income (expenses) | 5.80%-18.84M | 6.75%-18.4M | -1.96%-19.21M | -11.75%-78.74M | -14.59%-20.16M | -14.75%-20M | -12.71%-19.74M | -5.08%-18.84M | -11.28%-70.46M | -3.74%-17.59M |
| Non-operating interest expense | -5.80%18.84M | -6.75%18.4M | 1.96%19.21M | 11.75%78.74M | 14.59%20.16M | 14.75%20M | 12.71%19.74M | 5.08%18.84M | 11.28%70.46M | 3.74%17.59M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -100.22%-3K | -69.93%758K | 299.78%1.86M | 75.75%6.37M | 318.01%2.02M | 115.62%1.37M | 36.20%2.52M | -29.38%464K | -9.94%3.63M | -53.11%483K |
| Special income (charges) | -45.05%-4.98M | -6.35%-3.43M | ||||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | 45.05%4.98M | ---- | ---- | ---- | ---- | 6.35%3.43M | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 11.71%183.79M | 1.98%212.01M | 19.99%234.1M | 1.32%763.13M | -7.85%195.6M | -1.52%164.52M | 3.28%207.89M | 13.06%195.11M | 17.43%753.17M | 12.32%212.27M |
| Income tax | 11.19%47.67M | 1.41%53.43M | 19.37%59.96M | 0.88%194.19M | -9.74%48.41M | -0.55%42.88M | 3.39%52.68M | 12.12%50.23M | 14.30%192.5M | 1.37%53.63M |
| Net income | 11.90%136.12M | 2.17%158.58M | 20.20%174.15M | 1.47%568.94M | -7.21%147.2M | -1.86%121.65M | 3.25%155.21M | 13.39%144.88M | 18.55%560.68M | 16.58%158.63M |
| Net income continuous operations | 11.90%136.12M | 2.17%158.58M | 20.20%174.15M | 1.47%568.94M | -7.21%147.2M | -1.86%121.65M | 3.25%155.21M | 13.39%144.88M | 18.55%560.68M | 16.58%158.63M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Net income attributable to the company | 11.90%136.12M | 2.17%158.58M | 20.20%174.15M | 1.47%568.94M | -7.21%147.2M | -1.86%121.65M | 3.25%155.21M | 13.39%144.88M | 18.55%560.68M | 16.58%158.63M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 11.90%136.12M | 2.17%158.58M | 20.20%174.15M | 1.47%568.94M | -7.21%147.2M | -1.86%121.65M | 3.25%155.21M | 13.39%144.88M | 18.55%560.68M | 16.58%158.63M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 11.63%0.0144 | 1.83%0.0167 | 20.26%0.0184 | 1.35%0.0602 | -7.14%0.0156 | -1.53%0.0129 | 3.14%0.0164 | 13.33%0.0153 | 18.33%0.0594 | 15.86%0.0168 |
| Diluted earnings per share | 11.63%0.0144 | 1.83%0.0167 | 20.26%0.0184 | 1.35%0.0601 | -7.74%0.0155 | -1.53%0.0129 | 3.14%0.0164 | 13.33%0.0153 | 18.60%0.0593 | 15.86%0.0168 |
| Dividend per share | 25.00%0.015 | 40.00%0.014 | 80.00%0.018 | 50.00%0.042 | 25.00%0.01 | 50.00%0.012 | 66.67%0.01 | 66.67%0.01 | 29.23%0.028 | 60.00%0.008 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.